KalVista Pharmaceuticals, Inc. (KALV) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Arbutus Biopharma Corp.

SIGA Technologies, Inc.

Liquidia Corp.

Marinus Pharmaceuticals, Inc.

ARS Pharmaceuticals, Inc.

Nurix Therapeutics, Inc.

Coherus BioSciences, Inc.

Oric Pharmaceuticals, Inc.

Icosavax, Inc.

KalVista Pharmaceuticals, Inc.

Cullinan Therapeutics, Inc.

Why is KalVista Pharmaceuticals, Inc. ?

Unrated Stock - No Analysis Available

Real-Time Research Report

Verdict Report

No Data Found

Is KalVista Pharmaceuticals, Inc. for you?

High Risk, Medium Return

Absolute

Risk Adjusted

Volatility

KalVista Pharmaceuticals, Inc.

68.55%

0.17

60.99%

S&P 500

13.22%

0.61

20.17%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-100.00%

EBIT Growth (5y)

-221.42%

EBIT to Interest (avg)

-87.67

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-1.18

Sales to Capital Employed (avg)

0.06

Tax Ratio

1.88%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

100.00%

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

4.92

EV to EBIT

-3.10

EV to EBITDA

-3.12

EV to Capital Employed

-98.50

EV to Sales

PEG Ratio

Dividend Yield

ROCE (Latest)

Negative Capital Employed

ROE (Latest)

-121.18%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bullish

RSI

No Signal

Bollinger Bands

Bullish

Moving Averages

Mildly Bearish (Daily)

KST

Bearish

Bullish

Dow Theory

No Trend

Mildly Bearish

OBV

No Trend

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

10What is working for the Company

NET PROFIT(HY)

Higher at USD -110.71 MM

RAW MATERIAL COST(Y)

Fallen by -4,095% (YoY

NET SALES(9M)

Higher at USD 1.43 MM

DEBT-EQUITY RATIO (HY)

Lowest at -129.94 %

DEBTORS TURNOVER RATIO(HY)

Highest at 0.15 times

-27What is not working for the Company

OPERATING CASH FLOW(Y)

Lowest at USD -167.18 MM

ROCE(HY)

Lowest at -190.18%

PRE-TAX PROFIT(Q)

Lowest at USD -57.94 MM

NET PROFIT(Q)

Lowest at USD -60.1 MM

INTEREST(Q)

Highest at USD 3.52 MM

OPERATING PROFIT(Q)

Lowest at USD -58.76 MM

EPS(Q)

Lowest at USD -1.12

Here's what is working for KalVista Pharmaceuticals, Inc.

Net Sales

At USD 1.43 MM has Grown at inf%

Year on Year (YoY)

MOJO Watch

Sales trend is very positive

Net Sales (USD MM)

Debt-Equity Ratio

Lowest at -129.94 %

in the last five Semi-Annual periods

MOJO Watch

The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Debtors Turnover Ratio

Highest at 0.15 times

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Net Sales

Higher at USD 1.43 MM

than preceding 12 month period ended Jul 2025

MOJO Watch

In the nine month period the company has already crossed sales of the previous twelve months

Net Sales (USD MM)

Raw Material Cost

Fallen by -4,095% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for KalVista Pharmaceuticals, Inc.

Operating Cash Flow

Lowest at USD -167.18 MM and Fallen

In each year in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (USD MM)

Interest

At USD 3.52 MM has Grown at 19.67%

period on period (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (USD MM)

Pre-Tax Profit

Lowest at USD -57.94 MM and Fallen

In each period in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (USD MM)

Pre-Tax Profit

At USD -57.94 MM has Fallen at -43.26%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (USD MM)

Net Profit

Lowest at USD -60.1 MM and Fallen

In each period in the last five periods

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (USD MM)

Net Profit

At USD -60.1 MM has Fallen at -48.59%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (USD MM)

Interest

Highest at USD 3.52 MM

in the last five periods and Increased by 19.67% (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (USD MM)

Operating Profit

Lowest at USD -58.76 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (USD MM)

EPS

Lowest at USD -1.12

in the last five periods

MOJO Watch

Declining profitability; company has created lower earnings for shareholders

EPS (USD)